Free tool
Stocks far below their 52-week high
We cover 122 companies trading at least 50% below their own 52-week high. The median market value in the group is $25.45M. Across the group, the median move over the past trading day is −0.05%. 3% of the 116 with a 200-day average trade above it. Price change over the past year runs from −77.2% to +4.4% across the middle 80 percent of the group, with a median of −48.4%.
Other lists in this group
Table
122 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| COH.AX | Cochlear Limited | 136.01 AUD | +11.03% | −47.23% | −53.79% |
| 4506.T | Sumitomo Pharma Co., Ltd. | 1,436.50 JPY | +13.47% | −41.63% | −3.59% |
| EBO.AX | EBOS Group Limited | 17.51 AUD | −7.26% | −23.87% | −37.83% |
| 4DX.AX | 4DMedical Limited | 3.70 AUD | +13.34% | −18.61% | +669.79% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.37 AUD | +13.16% | −36.25% | −25.63% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | 13,370.00 KRW | +23.80% | −43.35% | −40.58% |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% |
| 317450.KS | MYUNGIN PHARM | 45,750.00 KRW | +14.09% | −25.73% | −55.96% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | 14,450.00 KRW | +18.93% | −62.41% | −40.38% |
| RAC.AX | Racura Oncology Ltd | 2.23 AUD | +12.06% | −22.30% | +87.39% |
| 4894.T | Cuorips Inc. | 5,720.00 JPY | +35.06% | −8.04% | −15.38% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | 4,110.00 KRW | +12.14% | +7.31% | +26.14% |
| 0120G0.KS | Samyang Biopharm | 54,100.00 KRW | +52.39% | +4.04% | +79.14% |
| 7777.T | 3-D Matrix, Ltd. | 361.00 JPY | +13.88% | −0.55% | +68.69% |
| 950210.KS | Prestige BioPharma Limited | 6,150.00 KRW | +10.81% | −54.65% | −55.91% |
| 4593.T | Healios K.K. | 286.00 JPY | +34.91% | +1.78% | −41.63% |
| HLS.AX | Healius Limited | 0.45 AUD | +20.00% | −50.55% | −50.55% |
| MYX.AX | Mayne Pharma Group Limited | 3.15 AUD | +19.32% | −1.25% | −37.38% |
| PGC.AX | Paragon Care Limited | 0.14 AUD | +13.60% | −35.45% | −58.24% |
| 504A.T | Innovacell Inc. | 570.00 JPY | +3.07% | −45.71% | −45.71% |
| EBR.AX | EBR Systems, Inc. | 0.29 AUD | +4.36% | −68.63% | −78.74% |
| 003520.KS | Yungjin Pharm. Co., Ltd. | 1,139.00 KRW | +0.44% | −43.75% | −43.89% |
| OCC.AX | Orthocell Limited | 0.76 AUD | +6.29% | −32.14% | −36.67% |
| 004310.KS | Hyundai Pharmaceutical Co., Ltd. | 6,020.00 KRW | +22.61% | −33.31% | +51.26% |
| DXB.AX | Dimerix Limited | 0.29 AUD | +20.83% | −47.27% | −34.83% |
| ONE.AX | Oneview Healthcare PLC | 0.19 AUD | +26.67% | −51.90% | −15.56% |
| 4563.T | AnGes, Inc. | 38.00 JPY | −19.15% | −40.62% | −60.42% |
| 4579.T | RaQualia Pharma Inc. | 568.00 JPY | +25.39% | −41.56% | +3.46% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | 0.22 AUD | +30.30% | −36.76% | −24.56% |
| 4888.T | Stella Pharma Corporation | 353.00 JPY | +18.06% | +66.51% | −11.75% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | 69.00 JPY | +21.05% | +64.29% | +35.29% |
| LDX.AX | Lumos Diagnostics Holdings Limited | 0.10 AUD | 0.00% | −68.75% | −25.93% |
| 4570.T | Immuno-Biological Laboratories Co., Ltd. | 1,145.00 JPY | +25.69% | −41.75% | +140.06% |
| AHC.AX | Austco Healthcare Limited | 0.22 AUD | −1.12% | −45.68% | −37.14% |
| 7776.T | CellSeed Inc. | 232.00 JPY | +15.42% | −16.85% | −47.39% |
| 4571.T | Nano Holdings, Inc. | 103.00 JPY | +8.42% | −27.46% | −31.79% |
| 000230.KS | Ildong Holdings Co., Ltd. | 6,420.00 KRW | +13.43% | −51.27% | −29.17% |
| IMM.AX | Immutep Limited | 0.05 AUD | +8.51% | −88.14% | −79.18% |
| ALA.AX | Arovella Therapeutics Limited | 0.06 AUD | −1.59% | −33.33% | −30.34% |
| SOM.AX | SomnoMed Limited | 0.33 AUD | −29.79% | −57.14% | −58.23% |
| 4263.T | SUSMED,Inc. | 469.00 JPY | −31.83% | −46.34% | −43.15% |
| PHX.AX | PharmX Technologies Limited | 0.10 AUD | −5.00% | −36.67% | −17.39% |
| M7T.AX | Mach7 Technologies Limited | 0.28 AUD | −6.67% | −58.52% | −13.85% |
| CYC.AX | Cyclopharm Limited | 0.52 AUD | −13.11% | −47.51% | −48.30% |
| BOT.AX | Botanix Pharmaceuticals Limited | 0.02 AUD | +5.26% | −85.19% | −86.67% |
| SHG.AX | Singular Health Group Ltd | 0.18 AUD | −12.50% | −33.96% | −46.15% |
| LGP.AX | Little Green Pharma Ltd | 0.07 AUD | −12.82% | −47.69% | −43.33% |
| COV.AX | Cleo Diagnostics Ltd | 0.35 AUD | +12.90% | −43.09% | +4.48% |
| 190A.T | CHORDIA THERAPEUTICS INC | 72.00 JPY | −1.37% | −35.71% | −59.32% |
| 6557.T | AIAI Group Corporation | 785.00 JPY | +13.11% | −45.18% | −47.35% |
| 4576.T | D. Western Therapeutics Institute, Inc. | 88.00 JPY | +17.33% | −12.87% | −12.00% |
| 520A.T | J-PHARMACEUTICALS CO LTD | 280.00 JPY | +4.09% | −60.00% | −60.00% |
| NUZ.AX | Neurizon Therapeutics Limited | 0.06 AUD | −6.67% | −31.71% | −63.87% |
| 4582.T | SymBio Pharmaceuticals Limited | 63.00 JPY | −4.55% | −30.00% | −57.43% |
| 2901.T | Wel-Dish.Incorporated | 161.00 JPY | −11.05% | −63.98% | −73.82% |
| 4586.T | MedRx Co., Ltd | 67.00 JPY | +4.69% | −40.18% | −39.64% |
| 177A.T | KOHJIN BIO CO LTD | 844.00 JPY | −4.31% | −41.14% | −51.28% |
| BMT.AX | Beamtree Holdings Limited | 0.13 AUD | −3.85% | −43.18% | −48.98% |
| IMU.AX | Imugene Limited | 0.07 AUD | −17.65% | −82.05% | −75.00% |
| 7061.T | Japan Hospice Holdings Inc. | 482.00 JPY | −14.69% | −56.46% | −62.40% |
| ENL.AX | Enlitic, Inc. | 0.01 AUD | −16.67% | −72.22% | −87.50% |
| RHY.AX | Rhythm Biosciences Limited | 0.10 AUD | +23.46% | −20.00% | 0.00% |
| 9229.T | Sunwels Co.,Ltd. | 117.00 JPY | −5.65% | −67.04% | −84.84% |
| CSX.AX | CleanSpace Holdings Limited | 0.39 AUD | −4.94% | −43.38% | −52.47% |
| VHL.AX | Vitasora Health Limited | 0.01 AUD | +38.10% | −36.96% | −50.00% |
| 4883.T | Modalis Therapeutics Corporation | 33.00 JPY | +10.00% | −43.10% | −62.07% |
| PIQ.AX | Proteomics International Laboratories Ltd | 0.17 AUD | +10.00% | −77.08% | −48.44% |
| NSB.AX | NeuroScientific Biopharmaceuticals Limited | 0.07 AUD | +9.84% | −33.00% | −58.12% |
| EZZ.AX | EZZ Life Science Holdings Limited | 0.56 AUD | +15.63% | −61.66% | −77.25% |
| TRJ.AX | Trajan Group Holdings Limited | 0.17 AUD | −19.05% | −75.54% | −81.82% |
| AGN.AX | Argenica Therapeutics Limited | 0.20 AUD | +30.00% | −36.07% | −69.53% |
| 003060.KS | Aprogen Biologics Inc. | 1,878.00 KRW | −7.26% | −76.67% | −79.60% |
| BDX.AX | BCAL Diagnostics Limited | 0.06 AUD | −17.81% | −40.00% | −6.25% |
| IIQ.AX | INOVIQ Ltd | 0.17 AUD | −12.82% | −57.50% | −58.54% |
| 4882.T | Perseus Proteomics Inc. | 149.00 JPY | +4.93% | −34.65% | −56.56% |
| RAD.AX | Radiopharm Theranostics Limited | 0.01 AUD | −28.57% | −60.00% | −63.64% |
| 118000.KS | METACARE CO., Ltd. | 1,297.00 KRW | +13.28% | −57.19% | −58.96% |
| 1AI.AX | Algorae Pharmaceuticals Limited | 0.01 AUD | −15.38% | −21.43% | +22.22% |
| 4881.T | FunPep Company Limited | 51.00 JPY | +2.00% | −37.04% | −55.65% |
| GSS.AX | Genetic Signatures Limited | 0.09 AUD | +50.00% | −64.49% | −71.00% |
| PCK.AX | PainChek Limited | 0.09 AUD | −6.00% | −67.02% | −77.07% |
| MX1.AX | Micro-X Limited | 0.03 AUD | −7.14% | −74.00% | −66.23% |
| 4438.T | Welby Inc. | 257.00 JPY | +5.76% | −8.87% | −23.96% |
| TRI.AX | TrivarX Limited | 0.02 AUD | 0.00% | −20.00% | +60.00% |
| IPD.AX | ImpediMed Limited | 0.01 AUD | +25.00% | −86.11% | −87.80% |
| VIT.AX | Vitura Health Limited | 0.03 AUD | −3.85% | −59.68% | −62.69% |
| AT1.AX | Atomo Diagnostics Limited | 0.02 AUD | 0.00% | −57.50% | −5.56% |
| 4598.T | Delta-Fly Pharma, Inc. | 104.00 JPY | +9.47% | −80.92% | −81.75% |
| CQT.AX | CONNEQT Health Limited | 0.01 AUD | −30.00% | −73.58% | −53.33% |
| RNV.AX | RENERVE FPO [RNV] | 0.07 AUD | −15.00% | −38.18% | −38.18% |
| 6190.T | PhoenixBio Co., Ltd. | 340.00 JPY | −2.58% | −29.17% | −15.63% |
| IMC.AX | Immuron Limited | 0.04 AUD | +8.82% | +5.71% | −46.38% |
| CVB.AX | CurveBeam AI Limited | 0.02 AUD | +11.11% | −73.68% | −85.71% |
| 1AD.AX | AdAlta Limited | 0.00 AUD | −25.00% | −25.00% | −25.00% |
| VBS.AX | Vectus Biosystems Limited | 0.17 AUD | +30.77% | +3.03% | +104.82% |
| AHE.AX | Adheris Health Limited | 0.01 AUD | −22.22% | −30.00% | −75.00% |
| FRE.AX | Firebrick Pharma Limited | 0.03 AUD | +7.41% | −45.28% | −61.33% |
| EPN.AX | Epsilon Healthcare Limited | 0.02 AUD | −17.39% | −40.62% | −20.83% |
| ECS.AX | ECS Botanics Holdings Ltd | 0.01 AUD | −16.67% | −16.67% | −33.33% |
| IBX.AX | Imagion Biosystems Limited | 0.01 AUD | −16.67% | −61.54% | −37.50% |
| BGT.AX | Bio-Gene Technology Limited | 0.02 AUD | −5.26% | −28.00% | −21.74% |
| PER.AX | PERCHERON FPO [PER] | 0.01 AUD | +66.67% | −47.37% | −54.55% |
| ACR.AX | Acrux Limited | 0.01 AUD | −9.09% | −33.33% | −33.33% |
| BIT.AX | Biotron Limited | 0.00 AUD | −20.00% | −42.86% | −50.00% |
| ADR.AX | Adherium Limited | 0.10 AUD | −4.76% | +1900.00% | +1900.00% |
| TRP.AX | Tissue Repair Ltd | 0.09 AUD | +4.76% | −77.44% | −70.67% |
| CAN.AX | Cann Group Limited | 0.00 AUD | 0.00% | −66.67% | −75.00% |
| VFX.AX | VISIONFLEX FPO [VFX] | 0.06 AUD | −5.17% | −42.11% | −56.00% |
| HIQ.AX | HITIQ Limited | 0.01 AUD | −16.67% | −76.19% | −72.22% |
| RGT.AX | Argent BioPharma Limited | 0.04 AUD | −36.36% | −50.00% | −74.07% |
| IVX.AX | Invion Limited | 0.04 AUD | −18.18% | −61.29% | −72.31% |
| GLH.AX | Global Health Limited | 0.06 AUD | −6.15% | −29.89% | −33.70% |
| EXL.AX | Elixinol Wellness Limited | 0.01 AUD | 0.00% | −22.22% | −58.82% |
| ANR.AX | Anatara Lifesciences Ltd | 0.01 AUD | −10.00% | −35.71% | 0.00% |
| NX1.AX | Nexalis Therapeutics Limited | 0.01 AUD | 0.00% | −50.00% | −50.00% |
| OSX.AX | Osteopore Limited | 0.00 AUD | 0.00% | −38.46% | −60.00% |
| CYP.AX | Cynata Therapeutics Limited | 0.01 AUD | −8.33% | −96.90% | −94.50% |
| BP8.AX | BPH Global Ltd | 0.00 AUD | −25.00% | −25.00% | −25.00% |
| OAK.AX | Oakridge International Limited | 0.06 AUD | −25.00% | −20.00% | −26.83% |
| CHM.AX | Chimeric Therapeutics Limited | 0.01 AUD | −76.74% | −95.00% | −96.67% |
| EPI.AX | EPIMINDER FPO [EPI] | 0.36 AUD | +29.09% | −65.53% | −72.90% |
| SLD.AX | Saluda Medical, Inc. | 0.61 AUD | +41.86% | −57.19% | −51.97% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.